James C. Madden
Known title: DirectorCIK: 0001408228
James C. Madden's purchase track record
James C. Madden has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/16/2023 | G | $92K | -1.4% | -7.3% | +9.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| G | ▲ Buy | Grant | 9,999 | $0 | 4/23/2026 | View on chart |
| G | ▲ Buy | Grant | 7,582 | $0 | 5/22/2025 | View on chart |
| G | ▲ Buy | Grant | 10,539 | $0 | 5/2/2024 | View on chart |
| G | ▲ Buy | Open Market | 500 | $18K | 5/16/2023 | View on chart |
| G | ▲ Buy | Open Market | 2,000 | $74K | 5/16/2023 | View on chart |
| G | ▲ Buy | Grant | 7,865 | $0 | 5/4/2023 | View on chart |
| G | ▲ Buy | Grant | 7,726 | $0 | 5/19/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Genpact Highlighted in Recent Stock Analysis Articles
Recent articles from Yahoo and ChartMill have discussed Genpact as a potential option for long-term investors. These pieces focus on the company's quality and position within the services sector. The stock currently trades near a key support level, with analysts maintaining a wide range of price targets.
Genpact Highlighted in Recent Stock Analysis Articles. Recent articles from Yahoo and ChartMill have discussed Genpact as a potential option for long-term investors. These pieces focus on the company's quality and position within the services sector. The stock currently trades near a key support level, with analysts maintaining a wide range of price targets.